GlaxoSmithKline Pharmaceuticals Limited Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

GlaxoSmithKline Pharmaceuticals Limited Company Profile :

GlaxoSmithKline Pharmaceuticals Limited is an Indian pharmaceutical company. The Company and its subsidiary are engaged in the business of manufacturing, distributing and trading in pharmaceuticals.

The Company’s prescription medicines range across therapeutic areas, and it also offers a range of vaccines for prevention of life-threatening diseases, such as pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough, small pox and influenza.

Company also provides healthcare solutions to patients, with a range of prescription medicines across areas covering anti-infectives, dermatology, gynecology, diabetes, oncology, cardiovascular disease and respiratory diseases.

The Company’s manufacturing unit is located at Nashik, and its clinical development center is located in Bangalore.


Glaxosmithkline Pharmaceuticals ResultsBSE Code : 500660
NSE Symbol : GLAXO
ISIN No. : INE159A01016
Industry :  Pharmaceuticals
Face Value : Rs. 10.00


If you are an investor who has shares of Glaxosmithkline Pharmaceuticals or you are an stock market analyst then i am sure you might for Quarterly Results of Glaxosmithkline Pharmaceuticals.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Glaxosmithkline Pharmaceuticals. That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Glaxosmithkline Pharmaceuticals

Glaxosmithkline Pharmaceuticals Q1 Results 2016-17 :

Glaxosmithkline Pharmaceuticals will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT  –
Tax
Net Profit
Equity
EPS

Glaxosmithkline Pharmaceuticals will announce its Q2 FY 2016-17 Results in the month of October 2016.

(Values in Cr.) Q2 Standalone Q2 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT  –
Tax
Net Profit
Equity
EPS

Glaxosmithkline Pharmaceuticals will announce its Q3 FY 2016-17 Results in the month of January 2017.

(Values in Cr.) Q3 Standalone Q3 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT  –
Tax
Net Profit
Equity
EPS

Glaxosmithkline Pharmaceuticals will announce its Q4 FY 2016-17 Results in the month of April 2017.

(Values in Cr.) Q4 Standalone Q4 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT  –
Tax
Net Profit
Equity
EPS

Glaxosmithkline Pharmaceuticals will announce its FY 2016-17 Results in the month of April 2017.

(Values in Cr.) FY 2016-17 Standalone FY 2016-17 Consolidated
Revenue
Other Income
Total Income
Expenditure
Interest
Depreciation
PBT  –
Tax
Net Profit
Equity
EPS

Note : We will update the results table above as and when results are announced. Visit again.

Glaxosmithkline Pharmaceuticals Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 2756.96 2768.35
Other Income 121.82  122.75
Total Income 2878.78  2891.1
Expenditure -2276.99 -2314.25
Interest 0.00
Depreciation -24.78 -24.78
PBT 577.01 579.46
Tax -201.80 -202.64
Net Profit 375.21 376.82
Equity 84.70 84.70
EPS 44.30 44.50

Note : If you like this information about Glaxosmithkline Pharmaceuticals Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.